Palomar Medical Technologies Q2 2010 Earnings Conference Call Transcript
The information in this conference call related to projections or other forward-looking statements may be relied upon subject to the previous Safe Harbor statement as of the date of this call. The information in this conference call is the property of Palomar and could not be reproduced, recorded or otherwise published without the expressed prior written consent of the company.
Joining us this morning are Dan Valente, Chairman; Joe Caruso, President and Chief Executive Officer; and Paul Weiner, Chief Financial Officer. I would now like to turn the call over to Dan.
Thanks, Kelly. Thank you all for tuning into this conference call. We have made up initial -- in operating goals again for the second quarter. As you know, Palomar will be entering a new and exciting phase in achieving the company’s direct-to-consumer commercialization goal. The [indiscernible] our plans to introduce our first home product by the end of 2010. Now let’s hear from Joe Caruso, President and our CEOJoe Caruso Thank you Dan. As the economy remains weak, it continues to affect the aesthetic device business in the short term. However, we have seen signs of stabilization with an increase in position confidence and an increase in lead generation and demos. We have yet to see any material change in the availability of credit for our customers. Fortunately, Palomar’s products are very well positioned for these challenging times. Even in this environment, our products make economic sense to our customers due to their high reach on an investment profile and the flexibility of our platform. We also continue to add technology in product configurations that fit into today’s economy. Our sales force has the ability to march our technology to fit not only the clinical needs of our customers but their financial constraints as well. We also benefit from a diversified business model that includes a significant portion of our revenues being derived from multiple sources. 41% of our revenues during the second quarter were generated from sources other than one time capital equipment sales.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV